When can the practicing physician suspect white coat hypertension? Statement from the working group on blood pressure monitoring of the european society of hypertension

American Journal of Hypertension

Volumn 16, Issue 1, 2003, Pages 87-91

  Verdecchia, Paolo ^a,g   O'Brien, Eoin ^h   Pickering, Thomas ^b   Staessen, Jan A ^c   Parati, Gianfranco ^d   Myers, Martin ^e   Palatini, Paolo ^f  

^a Ospedale Silvestrini   (Italy)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF PERUGIA   (Italy)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; DIAGNOSTIC TEST; EDITORIAL; HYPERTENSION; MEDICAL SOCIETY; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVATE PRACTICE; REIMBURSEMENT; WHITE COAT HYPERTENSION;

BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS' OFFICES;

EID: 0037235262     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03150-3     Document Type: Editorial

References (31)

1. CMS: Centers for Medicare & Medicaid Services. Medicare Coverage Policy - Decisions. Ambulatory Blood Pressure Monitoring (#CAG-00067N). 2001. http://www.hcfa.gov/coverage/8b3-ff.htm.
2. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH: How common is white-coat hypertension? JAMA 1988;259:225-228.
3. Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Petrin J, Sekkarie MA, Kjeldsen SEI: "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension 1990;16:617-623.
4. Pickering T, for an American Society of Hypertension Ad Hoc Panel: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996;9:1-11.
5. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G: Target organ damage, morbidity and mortality. Blood Pressure Monitoring 1999;4:303-317.
6. Verdecchia P: Prognostic value of ambulatory blood pressure. Current evidence and clinical implications. Hypertension 2000;35:844-851.
7. Verdecchia P: Reference values for ambulatory blood pressure and self-measured blood pressure based on prospective outcome data. Blood Pressure Monitoring 2001;6:323-327.
8. Verdecchia P, Staessen JA, White WB, Imai Y, O'Brien ET: Properly defining white coat hypertension. Eur Heart J 2001;23:106-109.
9. Staessen JA, Celis H, Hond ED, Giot C, Leeman M, O'Brien E, Vandenhoven G, Fagard R, THOP investigators: Comparison of conventional and automated blood pressure measurements: Interim analysis of the THOP trial. Treatment of hypertension according to home or office blood pressure. Blood Press Monit 2002;7:61-62.
10. Asmar R, Zanchetti A: Guidelines for the use of self-blood pressure monitoring: A summary report of the First International Consensus Conference. Group evaluation & measure of the French society of hypertension. J Hypertension 2000;18:493-508.
11. Mancia G, Bertineri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A: Effects of blood pressure measured by the doctor on patient's blood pressure and heart rate. Lancet 1983;2:695-698.
12. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, Porcellati C: White-coat hypertension and white-coat effect: Similarities and differences. Am J Hypertens 1995;8:790-798.
13. Myers MG, Haynes B, Rabkin SW: Canadian hypertension society guidelines for ambulatory blood pressure monitoring. Am J Hypertens 1999;12:1149-1157.
14. Myers MG, Reeves RA: White-coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991;4:844-849.
15. Myers MG, Reeves RA: White-coat effect in treated hypertensive patients: Sex difference. J Hum Hypertens 1995;9:729-733.
16. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G: Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998;31:1185-1189.
17. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C: White-coat hypertension. Lancet 1996;348:1444-1445.
18. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, de Leeuw PW, Dobovisek J, Jaaskivi M, Leonetti G, O'Brien E, Palatini P, Parati G, Rodicio JL, Vanhanen H, Webster J: Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000;102:1139-1144.
19. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG: Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001;38:238-245.
20. Owens PE, Lyons SP, Rodriguez SA, O'Brien ET: Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Human Hypertens 1998;12:743-748.
21. Owens P, Atkins N, O'Brien E: Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999;34:267-262.
22. Pickering TG: White coat hypertension: Time for action. Circulation 1998;97:1834-1836.
23. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R: Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997;278:1065-1072.
24. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, De Venuto G, Mattarei M, Cozzutti E, Gregori S, Mormino P, Pessina AC: White-coat hypertension: A selection bias? Harvest Study Investigators. Hypertension and ambulatory recording; Venetia study. J Hypertens 1998;16:977-984.
25. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on the detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2446.
26. Guidelines Subcommittee: 1999 WHO/ISH Guidelines for the management of hypertension. J Hypertens 1999;17:151-183.
27. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russel G: British Hypertension Society guidelines for hypertension management 1999: Summary. BMJ 1999;519:630-635.
28. Staessen JA, O'Brien ET, Atkins N, Amery AK, on behalf of the Ad-Hoc Working Group: Short report: Ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens 1993;11:1289-1297.
29. Sorof JM, Poffenbarger T, Franco K, Portman R: Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 2001;14:855-860.
30. Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC: Independent predictors of isolated clinic (white-coat) hypertension. J Hypertens 2001;19:1015-1020.
31. Bjorklund K, Lind L, Vessby B, Andren B, Lithell H: Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: A population-based study of elderly men. Circulation 2002;106:63-68.